ArticleArchives of clinical and medical case reports2026
Moyamoya Vasculopathy with Atypical Cogan's Syndrome: A Case Report.
Article in Archives of clinical and medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Cogan's syndrome (CS) is a rare autoimmune disorder involving audio-vestibular and ocular inflammation. While systemic vasculitis is a known complication, its association with Moyamoya-type cerebrovascular remodeling has not been previously documented. A 19-year-old Asian woman was diagnosed with atypical CS following a presentation of hyperpyrexia, unintentional weight loss, and severe bilateral sensorineural hearing loss. After five years of appropriate immunosuppressive treatment, she developed subacute headaches, hypertension, and left hemiparesis and paresthesia. Despite normal inflammatory markers, neuroimaging revealed right-sided internal carotid artery occlusion and extensive collateralization characteristic of Moyamoya syndrome. Genetic testing showed a variant of uncertain significance in SLC37A4. The patient underwent a right extracranial-intracranial (STA-MCA) bypass, resulting in complete resolution of neurological symptoms. The late emergence of Moyamoya suggests that chronic autoimmune-mediated vascular injury may trigger progressive steno-occlusive disease. Clinicians should consider Moyamoya syndrome as a differential for new neurological symptoms in CS patients, even when systemic inflammation appears controlled. To our knowledge, this is the first reported case of concurrent Cogan's syndrome and Moyamoya vasculopathy at time of writing this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.